Design of Anti-Tumor RNA Nanoparticles and Their Inhibitory Effect on Hep3B Liver Cancer
Biomolecules · 2025
DOI: 10.3390/biom16010045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Shuyi Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Plant Secondary Metabolism and Regulation of Zhejiang Province, College of Life Sciences and Medicine, Zhejiang Sci-Tech University…. Hauptthemen laut MEDLINE: Nanoparticles, Liver Neoplasms, RNA, Small Interfering, Carcinoma, Hepatocellular. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Sciences Foundation of China, National Natural Sciences Foundation of China.
Abstract (Originalsprache)
RNA interference (RNAi) holds promise as a gene-silencing therapy for liver cancer but faces challenges related to siRNA instability, short half-life, and inefficient cellular uptake. In this study, we designed a self-assembling RNA nanoparticle targeting three oncogenes—hTERT, BIRC5, and FGFR1—key drivers of cancer progression. These RNA nanoparticles demonstrated enhanced stability and specificity, eliminating the need for conventional toxic delivery carriers. Functional assays revealed that the nanoparticles effectively suppressed the proliferation, migration, tumor growth and apoptosis of a Hepatocellular carcinoma cell line, Hep3B. The nanoparticles exhibited excellent safety and efficacy in xenograft model mice, without off-target toxicity. This work introduces a scalable, biocompatible RNA nanoparticle platform with multi-targeting capability, paving the way for improved RNAi-based therapeutics. Our findings offer a promising strategy for advancing personalized cancer therapies and underscore the broader potential of RNA nanotechnology in addressing complex malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Plant Secondary Metabolism and Regulation of Zhejiang Province, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
- Zhejiang Sci-Tech University Shaoxing Academy of Biomedicine, Shaoxing 312366, China.
ORCID-Profile: Zhekai Liu, Weibo Jin
Förderung
- the Natural Sciences Foundation of China
- National Natural Sciences Foundation of China
Zitieren
APA
Sun, S., Yan, L., Liu, Z., & Jin, W. (2025). Design of Anti-Tumor RNA Nanoparticles and Their Inhibitory Effect on Hep3B Liver Cancer. Biomolecules. https://doi.org/10.3390/biom16010045
Vancouver
Sun S, Yan L, Liu Z, Jin W. Design of Anti-Tumor RNA Nanoparticles and Their Inhibitory Effect on Hep3B Liver Cancer. Biomolecules. 2025. doi:10.3390/biom16010045
BibTeX
@article{Sun2025,
author = {Sun, Shuyi and Yan, Ling and Liu, Zhekai and Jin, Weibo},
title = {Design of Anti-Tumor RNA Nanoparticles and Their Inhibitory Effect on Hep3B Liver Cancer},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom16010045}
}
EUVIMED